Overview

The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study

Status:
COMPLETED
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
We aimed to evaluate the usability and efficacy of omalizumab in allergic rhinitis and its potential as an alternative treatment option.
Phase:
PHASE4
Details
Lead Sponsor:
Yuzuncu Yl University
Treatments:
montelukast
Omalizumab